Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis

BACKGROUND: With widespread resistance to antimonials in Visceral Leishmaniasis (VL) in the Indian subcontinent, Miltefosine (MIL) has been introduced as the first line therapy. Surveillance of MIL susceptibility in natural populations of Leishmania donovani is vital to preserve it and support the V...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bhandari, Vasundhra, Kulshrestha, Arpita, Deep, Deepak Kumar, Stark, Olivia, Prajapati, Vijay Kumar, Ramesh, V., Sundar, Shyam, Schonian, Gabriele, Dujardin, Jean Claude, Salotra, Poonam
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3358331/
https://ncbi.nlm.nih.gov/pubmed/22629478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0001657
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars